The coronavirus pandemic has catalyzed a greater need for remote patient monitoring (RPM) tools, spurred on by their ability to enable the observation and treatment of patients from afar. RPM solutions gather patients’ biometric data and apply analytics, providing physicians with a holistic view of their health—enabling clinicians to intervene before a patient’s condition deteriorates.
The future of the RPM space looks bright, with adoption of the tech projected to grow steadily even once the pandemic is out of the picture. Insider Intelligence estimates 30 million US patients, or 11.2% of the population, will use RPM tools by 2024—marking 28.2% growth from 23.4 million patients in 2020.
The US government has relaxed regulations around RPM tools, making it easier for these solutions to make it to market fast, setting the stage for even greater proliferation of the tech. For example, in April 2020, chronic condition management company Livongo received an...
| | Report Preview * This chart and data were pulled from The Remote Patient Monitoring Report by Insider Intelligence. Purchase the report below for immediate access. | | | The coronavirus pandemic has catalyzed a greater need for remote patient monitoring (RPM) tools, spurred on by their ability to enable the observation and treatment of patients from afar. RPM solutions gather patients’ biometric data and apply analytics, providing physicians with a holistic view of their health—enabling clinicians to intervene before a patient’s condition deteriorates.
The future of the RPM space looks bright, with adoption of the tech projected to grow steadily even once the pandemic is out of the picture. Insider Intelligence estimates 30 million US patients, or 11.2% of the population, will use RPM tools by 2024—marking 28.2% growth from 23.4 million patients in 2020.
The US government has relaxed regulations around RPM tools, making it easier for these solutions to make it to market fast, setting the stage for even greater proliferation of the tech. For example, in April 2020, chronic condition management company Livongo received an... | | | Other Related Reports | | The pharmaceutical industry has been lagging behind other industries when it comes to digitization, but incumbents are... ACCESS FULL REPORT | Digital therapeutics (DTx) were gaining popularity as tools to help slash the US’ $3 trillion annual spending on chronic disease, and the pandemic has... ACCESS FULL REPORT |
|
| | To learn more about Insider Intelligence and our Digital Health coverage, click below and fill out the form, and a member of our team will be in touch with you. | | |
|
|
| |
| |
